Tandem Diabetes Care | TNDM - Trade Debtors


Tandem Diabetes Care reported $162.06M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
Accuray USD 91.79M 7.07M Sep/2024
Align Technology USD 1.15B 23.28M Jun/2026
AtriCure USD 79.98M 8.67M Jun/2026
Baxter International USD 1.86B 158M Jun/2026
Becton, Dickinson and Co. USD 2.36B 159M Jun/2026
Boston Scientific USD 3.03B 101M Mar/2026
Cooper Companies USD 809.2M 2.1M Mar/2026
Dexcom USD 1.27B 175.4M Jun/2026
Edwards Lifesciences USD 973M 60.9M Mar/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Globus Medical USD 739.28M 3.84M Jun/2026
ICU Medical USD 183.53M 43.29M Jun/2026
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 588.7M 44M Jun/2026
Integra LifeSciences USD 267.19M 2.78M Jun/2026
Intuitive Surgical USD 1.67B 77.6M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Medtronic USD 6.64B 284M Mar/2026
Merit Medical Systems USD 250.9M 23.9M Jun/2026
Orthofix International USD 135.75M 4.94M Dec/2025
Roche Holding CHF 13.34B 1.44B Jun/2026
Stryker USD 3.74B 172M Jun/2026
Tandem Diabetes Care USD 162.06M 21.39M Jun/2026
Teleflex USD 364.61M 917K Jun/2026
Zimmer Biomet Holdings USD 1.77B 40.9M Jun/2026